Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 28, 2012, Pages 11270-11275

  Yeste, Ada ^a   Nadeau, Meghan ^a   Burns, Evan J ^a   Weiner, Howard L ^a   Quintana, Francisco J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1' INDOLE 3' CARBONYL) THIAZOLE 4 CARBOXYLIC ACID METHYL ESTER; ESTER DERIVATIVE; MYELIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NANOPARTICLE; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEGRADATION KINETICS; GEL ELECTROPHORESIS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; EPITOPES, T-LYMPHOCYTE; GENES, REPORTER; HUMANS; IMMUNE SYSTEM; LIGANDS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSOMES, LIVER; MULTIPLE SCLEROSIS; MYELIN SHEATH; NANOPARTICLES; NANOTECHNOLOGY; T-LYMPHOCYTES, REGULATORY;

EID: 84863949288     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1120611109     Document Type: Article

References (47)

1. McFarland HF, Martin R (2007) Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol 8:913-919. (Pubitemid 47300005)
2. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10:490-500.
3. Roncarolo MG, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212:28-50. (Pubitemid 44116698)
4. Buckner JH (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10:849-859.
5. Wing K, Sakaguchi S (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11:7-13.
6. Bluestone JA, Thomson AW, Shevach EM, Weiner HL (2007) What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 7:650-654. (Pubitemid 47123553)
7. Quintana FJ, et al. (2010) Adaptive autoimmunity and Foxp3-based immunoregulation in zebrafish. PLoS ONE 5:e9478.
8. Apetoh L, et al. (2010) The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat Immunol 11:854-861.
9. Gandhi R, et al. (2010) Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat Immunol 11:846-853.
10. Quintana FJ, et al. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453:65-71. (Pubitemid 351630328)
11. Quintana FJ, et al. (2010) An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 107:20768-20773.
12. Wu HY, et al. (2011) In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling. PLoS ONE 6:e23618.
13. Hauben E, et al. (2008) Activation of the aryl hydrocarbon receptor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 112:1214-1222.
14. Mezrich JD, et al. (2010) An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 185:3190-3198.
15. Nguyen NT, et al. (2010) Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc Natl Acad Sci USA 107:19961-19966.
16. Qian X, et al. (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26:83-90.
17. Benny O, et al. (2008) An orally delivered small-molecule formulation with anti-angiogenic and anticancer activity. Nat Biotechnol 26:799-807. (Pubitemid 351961454)
18. Jewell CM, López SC, Irvine DJ (2011) In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles. Proc Natl Acad Sci USA 108:15745-15750.
19. Kasturi SP, et al. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:543-547.
20. Leuschner F, et al. (2011) Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol 29:1005-1010.
21. Korn T, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13:423-431. (Pubitemid 46559831)
22. Joshi HM, Bhumkar DR, Joshi K, Pokharkar V, Sastry M (2006) Gold nanoparticles as carriers for efficient transmucosal insulin delivery. Langmuir 22:300-305. (Pubitemid 43063552)
23. Sanvicens N, Marco MP (2008) Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol 26:425-433.
24. Bergander L, et al. (2004) Metabolic fate of the Ah receptor ligand 6-formylindolo [3,2-b]carbazole. Chem Biol Interact 149:151-164. (Pubitemid 39402931)
25. Steinman RM, Banchereau J (2007) Taking dendritic cells into medicine. Nature 449:419-426. (Pubitemid 47509552)
26. Jones PB, Galeazzi DR, Fisher JM, Whitlock JP, Jr. (1985) Control of cytochrome P1-450 gene expression by dioxin. Science 227:1499-1502. (Pubitemid 15146998)
27. Bettelli E, et al. (2003) Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med 197:1073-1081. (Pubitemid 36570063)
28. Vanderlugt CL, Miller SD (2002) Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2:85-95. (Pubitemid 37323232)
29. Kerkvliet NI, et al. (2009) Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes. Immunotherapy 1:539-547.
30. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2008) Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 105:9721-9726. (Pubitemid 352031367)
31. Singh NP, et al. (2011) Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 6:e23522.
32. Bettelli E, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-238.
33. Garren H, et al.; BHT-3009 Study Group (2008) Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis. Ann Neurol 63:611-620.
34. Quintana FJ, Carmi P, Mor F, Cohen IR (2003) DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: Identification of a regulatory HSP60 peptide. J Immunol 171:3533-3541. (Pubitemid 37254555)
35. Ochi H, et al. (2006) Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. Nat Med 12:627-635. (Pubitemid 43865230)
36. Gabrysová L, et al. (2009) Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells. J Exp Med 206:1755-1767.
37. Juryńczyk M, et al. (2010) Immune regulation of multiple sclerosis by transdermally applied myelin peptides. Ann Neurol 68:593-601.
38. Claman HN, Miller SD (1976) Requirements for induction of T cell tolerance to DNFB: Efficiency of membrane-associated DNFB. J Immunol 117:480-485.
39. Tsai S, et al. (2010) Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32:568-580.
40. McAteer MA, Choudhury RP (2009) Chapter 4 - applications of nanotechnology in molecular imaging of the brain. Prog Brain Res 180:72-96.
41. Stein CS, St Louis J, Gilbert JJ, Strejan GH (1990) Treatment of spinal cord-induced experimental allergic encephalomyelitis in the Lewis rat with liposomes presenting central nervous system antigens. J Neuroimmunol 28:119-130. (Pubitemid 20187685)
42. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025-1033. (Pubitemid 20343201)
43. Büyüktimkin B, et al. (2012) Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis. Mol Pharm 9:979-985.
44. Robinson WH, et al. (2003) Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol 21:1033-1039. (Pubitemid 37064732)
45. Kanter JL, et al. (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138-143. (Pubitemid 43050089)
46. Quintana FJ, et al. (2012) Antigen microarrays identify CNS-produced autoantibodies in RRMS. Neurology 78:532-539.
47. Quintana FJ, et al. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci USA 105:18889-18894.